- Meet Our Team
- Cases We Handle
- Video Center
- Case Results
The FDA has recalled Medisca, Inc.’s L-Citrulline Supplements because certain lots of the product were tested and found to be sub-potent or non-existent in the product.
L-Citrulline is a supplement often prescribed to treat Urea Cycle Disorder (UCD), a rare but serious genetic disorder affecting the body’s ability to remove nitrogen from the blood. The urea cycle removes nitrogen, a waste product of protein metabolism, from the blood converting it to urea, which is removed from the body through urine. UCD affects the body’s ability to remove the blood, causing the nitrogen to accumulate as ammonia. Ammonia can be a highly toxic substance, causing hyperammonemia. If ammonia is carried by blood into the brain, it can cause severe brain damage, coma, and death.
The FDA’s warning explains that Medisca’s recalled lots did not contain L-Citrulline at all, but rather a different compound, N-acetyl-leucine. Patients, doctors, and caregivers should not use any products in the recalled lots, and in fact, several adverse event reports have been made to the FDA.
The Gomez Trial Attorneys are reviewing and accepting clients who purchased and/or used the L-Citrulline product produced by Medisca.
No Fees Unless We Recover Money On Your Behalf